Nerve Conduction Velocity in Diabetic Children
Prevalence of Pathological Nerve Conduction Velocity in Children and Adolescents Suffering From Diabetes Mellitus Type I
1 other identifier
observational
40
1 country
1
Brief Summary
The investigators intend to study children and adolescents from 8 to 18 years suffering from diabetes mellitus type 1 for more than one year. The patients will undergo a detailed clinical examination for anthropometric data, blood pressure, blood and urine. Motor and sensory nerve conduction velocity will be examined by electrical stimulation using surface patch electrodes. The nerves to be examined are the nervus tibialis anterior, nervus medianus and nervus peroneus. Primary outcome: How many children and adolescents suffering from diabetes mellitus type 1 (duration of disease \> 1 year, age 8 to 18a, insulin requirement \> 0.5 IU/kg/d) show pathological nerve conduction velocity? Secondary outcome: Is there a significant difference in nerve conduction velocity between the group of diabetic patients and the control group of healthy young people? Does the quality of disease control have an influence on nerve conduction velocity? Is there a correlation between nerve conduction velocity in our study patients and the Young Score? Is there a correlation between pathological nerve conduction velocity and other long-term vascular complications (nephropathy, retinopathy)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 20, 2009
CompletedFirst Posted
Study publicly available on registry
November 23, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedSeptember 27, 2011
September 1, 2011
1.2 years
November 20, 2009
September 24, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
How many children and adolescents suffering from diabetes mellitus type 1 (duration of disease > 1 year, age 8 to 18a, insulin requirement > 0.5 IU/kg/d) show pathological nerve conduction velocity?
One electrophysiological investigation (nerve conduction velocity)
Secondary Outcomes (1)
Is there a correlation between nerve conduction velocity in our study patients and the Young Score?
One clinical investigation (Young score)
Eligibility Criteria
children and adolescents with diabetes mellitus type 1 (duration of disease \> 1 year, age 8 to 18a, insulin requirement \> 0.5 IU/kg/d)
You may qualify if:
- Children and adolescents with diabetes mellitus type 1 (duration of disease \> 1 year, age 8 to 18a, insulin requirement \> 0.5 IU/kg/d)
You may not qualify if:
- No consent
- Diabetic children with duration of diabetes \< 1 year, age \<8 or \>18 year or insulin requirement \> 0.5 IU/kg/d
- Blood glucose levels \<50 or \>350 mg/dl
- Children with chronic diseases, handicapped children, children with cancer, chronic renal impairment, or neurological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatrics, University Teaching Hospital, Landeskrankenhaus Feldkirch
Feldkirch, 6800, Austria
Related Publications (6)
Trotta D, Verrotti A, Salladini C, Chiarelli F. Diabetic neuropathy in children and adolescents. Pediatr Diabetes. 2004 Mar;5(1):44-57. doi: 10.1111/j.1399-543X.2004.00041.x.
PMID: 15043690BACKGROUNDdos Santos LH, Bruck I, Antoniuk SA, Sandrini R. Evaluation of sensorimotor polyneuropathy in children and adolescents with type I diabetes: associations with microalbuminuria and retinopathy. Pediatr Diabetes. 2002 Jun;3(2):101-8. doi: 10.1034/j.1399-5448.2002.30207.x.
PMID: 15016164BACKGROUNDNelson D, Mah JK, Adams C, Hui S, Crawford S, Darwish H, Stephure D, Pacaud D. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2006 Dec;7(6):305-10. doi: 10.1111/j.1399-5448.2006.00208.x.
PMID: 17212597BACKGROUNDMeh D, Denislic M. Subclinical neuropathy in type I diabetic children. Electroencephalogr Clin Neurophysiol. 1998 Jun;109(3):274-80. doi: 10.1016/s0924-980x(98)00017-4.
PMID: 9741795BACKGROUNDHyllienmark L, Brismar T, Ludvigsson J. Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia. 1995 Jun;38(6):685-92. doi: 10.1007/BF00401840.
PMID: 7672490BACKGROUNDDorchy H, Noel P, Kruger M, de Maertelaer V, Dupont E, Toussaint D, Pelc S. Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG. Eur J Pediatr. 1985 Nov;144(4):310-5. doi: 10.1007/BF00441770.
PMID: 3865772BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Burkhard Simma, MD, Prof
Landeskrankenhaus Feldkirch
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Simma B, MD
Study Record Dates
First Submitted
November 20, 2009
First Posted
November 23, 2009
Study Start
May 1, 2009
Primary Completion
July 1, 2010
Study Completion
July 1, 2011
Last Updated
September 27, 2011
Record last verified: 2011-09